Skip to main content
. 2020 May 30;8(6):827. doi: 10.3390/microorganisms8060827

Table 5.

Resistance profile, replicon type, and virulence genes identified in the EC121’s plasmids transferred to E. coli K-12 strains.

Traits EC121 J53 C600 ACG04 ACC09
Antimicrobial a
ceftazidime 64 0.25 0.25 8 2
ceftriaxone ≥64 ≤0.125 ≤0.125 >64 >64
cefepime 16 0.25 ≤0.125 16 2
piperacillin/tazobactam >256 2 2 8 2
aztreonam >32 ≤0.125 ≤0.125 16 4
amikacin 4 2 2 16 2
gentamycin 16 0.5 0.5 32 0.5
trimethoprim/sulfamethoxazole >128 ≤0.25 ≤0.25 >128 >128
ciprofloxacin >64 ≤0.125 ≤0.125 ≤0.125 ≤0.125
minocycline 16 1 1 4 1
tigecycline 1 0.25 0.125 0.25 0.125
Replicon type b
IncHI2 + - - + +
IncL/M + - - + -
IncFIB + - - + -
IncN + - - + -
Virulence c
hlyF + - - + -
iroN + - - + -
sitA + - - + -
Resistance gene
bla CTX-M + - - + +

a The antimicrobial resistance phenotype of transconjugant strains was assessed by minimum inhibitory concentration (MIC), performed using the broth microdilution method according to EUCAST guideline, and expressed in µg/mL. Bold values indicate an increased MIC value when comparing strains bearing plasmids with its receptor strain which is devoid of plasmids; b replicons identified in EC121 by PlasmidFinder, and screened by PCR; c virulence genes identified in EC121 genome and screened by PCR; + for the presence of the gene; - for the absence of the gene.